ArticleBMJ open2023

Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.

Duc Binh Phan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.